Potentiation of Anti-Myeloma Activity of Daratumumab with Combination of Cyclophosphamide, Lenalidomide or Bortezomib Via a Tumor Secretory Response That Greatly Augments Macrophage-Induced ADCP / Rigalou, A; Ryan, A; Natoni, A; Chiu, C; Sasser, K; O'Dwyer, Me. - In: BLOOD. - ISSN 0006-4971. - 128:22(2016), pp. 2101-2101. [10.1182/blood.V128.22.2101.2101]
Potentiation of Anti-Myeloma Activity of Daratumumab with Combination of Cyclophosphamide, Lenalidomide or Bortezomib Via a Tumor Secretory Response That Greatly Augments Macrophage-Induced ADCP
Natoni, AInvestigation
;
2016
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
